Abstract
Studies have shown that the expression profile of Wnt signaling pathway is very important in lung adenocarcinoma (LAD) and some lncRNAs can regulate the expression of key molecules of Wnt pathway. However, Wnt pathway related lncRNAs are not systematically analyzed and detected in lung adenocarcinoma. We used a high-throughput microarray to compare the lncRNA expression profiles in LAD and corresponding normal tissue (NT) samples. Several candidate Wnt pathway related lncRNAs were verified by real-time quantitative reverse transcription polymerase chain reaction (PCR) analysis. We found that 232 Wnt pathway related lncRNAs were obviously expressed (≥2-fold change) in lung adenocarcinoma samples and 13 Wnt pathway related lncRNAs were aberrantly expressed in lung adenocarcinoma compared with matched histologically normal lung tissues by qPCR. Among these, RP11-181G12.2 and RP11-89 K21.1 were the most aberrantly expressed lncRNAs. Our study ascertained the expression of Wnt pathway related lncRNAs in lung adenocarcinoma. The results revealed that many Wnt pathway related lncRNAs were differentially expressed in lung adenocarcinoma tissues, suggesting that they may play a key role in tumor development.
Similar content being viewed by others
References
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics, 2005. CA: a Cancer Journal for Clinicians 55:10–30
Gupta A, Verma A, Mishra AK, Wadhwa G, Sharma SK, Jain CK (2013) The wnt pathway: emerging anticancer strategies. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 7:138–147
Le PN, McDermott JD, Jimeno A (2015) Targeting the wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28. Pharmacology & Therapeutics. 146:1–11
Stewart DJ, Chang DW, Ye Y, Spitz M, Lu C, Shu X, Wampfler JA, Marks RS, Garces YI, Yang P, Wu X (2014) Wnt signaling pathway pharmacogenetics in non-small cell lung cancer. The Pharmacogenomics Journal 14:509–522
Stewart DJ (2014) Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst 106:djt356
Yao L, Sun B, Zhao X, Zhao X, Gu Q, Dong X, Zheng Y, Sun J, Cheng R, Qi H, An J (2014) Overexpression of Wnt5a promotes angiogenesis in NSCLC. BioMed Research International 2014:832562
Qiu M, Xu Y, Wang J, Zhang E, Sun M, Zheng Y, Li M, Xia W, Feng D, Yin R, Xu L (2015) A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27. Cell Death & Disease 6:e1858
Wang Y, Chen W, Chen J, Pan Q, Pan J (2014) LncRNA expression profiles of EGFR exon 19 deletions in lung adenocarcinoma ascertained by using microarray analysis. Medical Oncology. 31:137
Cai Y, He J, Zhang D (2015) Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the wnt signaling pathway. OncoTargets and Therapy 8:2657–2664
Ma Y, Yang Y, Wang F, Moyer MP, Wei Q, Zhang P, Yang Z, Liu W, Zhang H, Chen N, Wang H, Wang H, Qin H (2015) Long non-coding RNA CCAL regulates colorectal cancer progression by activating wnt/beta-catenin signalling pathway via suppression of activator protein 2alpha. doi:10.1136/gutjnl-2014-308392
Wang Y, He L, Du Y, Zhu P, Huang G, Luo J, Yan X, Ye B, Li C, Xia P, Zhang G, Tian Y, Chen R, Fan Z (2015) The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of wnt signaling. Cell Stem Cell 16:413–425
Carrion K, Dyo J, Patel V, Sasik R, Mohamed SA, Hardiman G, Nigam V (2014) The long non-coding HOTAIR is modulated by cyclic stretch and WNT/beta-CATENIN in human aortic valve cells and is a novel repressor of calcification genes. PLoS ONE 9:e96577
Wang G, Li Z, Zhao Q, Zhu Y, Zhao C, Li X, Ma Z, Li X, Zhang Y (2014) LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the wnt/beta-catenin signaling pathway. Oncology Reports. 31:1839–1845
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y (2014) Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating wnt signaling. The FEBS Journal 281:1750–1758
Ren S, Peng Z, Mao JH, Yu Y, Yin C, Gao X, Cui Z, Zhang J, Yi K, Xu W, Chen C, Wang F, Guo X, Lu J, Yang J, Wei M, Tian Z, Guan Y, Tang L, Xu C, Wang L, Gao X, Tian W, Wang J, Yang H, Wang J, Sun Y (2012) RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Research. 22:806–821
Acknowledgments
Funding/Grant Support/Acknowledgments: This study was financially supported by the National Natural Science Foundation of China (81401736), Wenzhou Municipal Science and Technology Bureau, China (Y20140024, Y20140032), and the Zhejiang Provincial Health Department (No. 2014KYA133). We thank all the donors who devoted to the Microarray service at KangChen Bio-technology Company at Shanghai.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
These conflicts did not interfere with the conduct of this study. All other authors have no other conflict of interest to declare.
Additional information
Jie Chen and Lijuan Hu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Chen, J., Hu, L., Chen, J. et al. Detection and Analysis of Wnt Pathway Related lncRNAs Expression Profile in Lung Adenocarcinoma. Pathol. Oncol. Res. 22, 609–615 (2016). https://doi.org/10.1007/s12253-016-0046-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-016-0046-9